Orexigen

These 4 Biotech Stocks Have Been On Fire
Yahoo/Benzinga
Mon, 12/8/14 - 11:12 pm
Agios Pharmaceuticals
Achillion
Amicus Therapeutics
Orexigen
The Odds Of Success For The New Obesity Drugs
CP Wire
Mon, 12/8/14 - 11:45 am
obesity
Belviq
Contrave
Qsymia
Arena Pharmaceuticals
Vivus
Orexigen
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:30 am
diabetes
obesity
Arena Pharmaceuticals
Novo Nordisk
AstraZeneca
Orexigen
Vivus
Farxiga
Victoza
Invokana
For This Obesity Drug, Europe Trumps the U.S.
Motley Fool
Tue, 11/18/14 - 10:06 am
Orexigen
Europe
Contrave
obesity
2 Skyrocketing Biotech Stocks In A Stalling Market
Yahoo/Benzinga
Mon, 11/17/14 - 04:40 pm
Orexigen
Achillion
Obesity drug war may be about more than marketing to the overweight
Medical Marketing and Media
Wed, 11/12/14 - 04:52 pm
obesity
Contrave
Orexigen
Eisai
Arena And Vivus Investors Need To Watch Orexigen
Seeking Alpha
Tue, 11/11/14 - 10:38 am
Arena Pharmaceuticals
Orexigen
Vivus
obesity
Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
TheStreet.com
Mon, 11/10/14 - 04:08 pm
Orexigen
Contrave
Europe
Orexigen beats 3Q profit forecasts
Yahoo/AP
Mon, 11/10/14 - 08:12 am
Orexigen
earnings
Orexigen's Contrave Has Modest Start
Seeking Alpha
Mon, 11/3/14 - 06:42 pm
Orexigen
Contrave
obesity
3 Pharma Companies Fighting Obesity
Yahoo/Benzinga
Thu, 10/30/14 - 05:33 pm
obesity
Orexigen
Arena
Vivus
Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets
Yahoo
Mon, 10/20/14 - 09:10 am
Takeda
Orexigen
Contrave
obesity
Orexigen pockets $100M in milestone cash for Contrave
Fierce Biotech
Wed, 10/15/14 - 12:26 pm
Orexigen
Contrave
Takeda
Armed with 900 reps, Takeda aims for the Contrave marketing hat-trick
Fierce Pharma Marketing
Wed, 09/17/14 - 05:10 pm
Takeda
drug reps
Contrave
obesity
Orexigen
Selling Obesity Drugs to Americans Shouldn't Be This Hard
Bloomberg/Businessweek
Mon, 09/15/14 - 09:18 am
obesity
Orexigen
Contrave
Qsymia
Belviq
Arena Pharmaceuticals
Eisai
Safety warnings will hold back new obesity treatment Contrave
Pharmaphorum
Fri, 09/12/14 - 08:41 am
Orexigen
Takeda
obesity
Contrave
Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised
TheStreet.com
Thu, 09/11/14 - 05:21 pm
Orexigen
Contrave
FDA
obesity
FDA Approves Contrave Weight Loss Drug From Orexigen And Takeda
Forbes
Wed, 09/10/14 - 08:37 pm
FDA
Contrave
obesity
Orexigen
Takeda
More Obesity Drugs Seek to Enter Still Struggling Market
Bloomberg
Tue, 09/9/14 - 08:08 am
obesity
Orexigen
Novo Nordisk
NB32
liraglutide
Victoza
Takeda
September Biotech Calendar
TheStreet.com
Tue, 08/26/14 - 10:08 am
Keryx
Orexigen
AstraZeneca
Nektar
Salix
Alimera
Amarin
Merck
EXACT Sciences
NPS Pharmaceuticals

Pages